Elin Karlsson

The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials

Elin Karlsson, Gizeh Pérez‐Tenorio, Risul Amin et al. · Breast Cancer Research · 2013 · 107 citations · Full text

Medicine, Endocrinology, Oncology +17

Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit

Josefine Bostner, Elin Karlsson, Muneeswaran Jayachandra Pandiyan et al. · Breast Cancer Research and Treatment · 2012 · 99 citations · Full text

Medicine, Endocrinology, Oncology +17

High‐resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1

Elin Karlsson, Marie Ahnström Waltersson, Josefine Bostner et al. · Genes Chromosomes and Cancer · 2011 · 81 citations · Full text

Medicine, Genetics, Oncology +16

Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer

Gizeh Pérez‐Tenorio, Elin Karlsson, Marie Ahnström Waltersson et al. · Breast Cancer Research and Treatment · 2010 · 69 citations · Full text

Medicine, Cancer Biology, Oncology +16

The Role of MicroRNA-200 in Progression of Human Colorectal and Breast Cancer

Linda Bojmar, Elin Karlsson, Sander Ellegård et al. · PLoS ONE · 2013 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +17